Navigation Links
Pharmaceuticals Wholesaling in Australia Industry Market Research Report Now Updated by IBISWorld
Date:8/4/2014

Melbourne, Australia (PRWEB) August 05, 2014

Operators in the Pharmaceuticals Wholesaling industry in Australia are an important interface between local and international pharmaceutical manufacturers and the nation's 5,300 community pharmacies. Pharmaceutical wholesalers are involved in the procurement, distribution and sale of a range of pharmaceutical and medicinal products. These products include prescription medicines, pharmacy-only medicines, over-the-counter (OTC) medicines and other healthcare products.

According to IBISWorld industry analyst Arna Richardson, “following relatively strong revenue growth in the early 2000s, growth rates began to falter in 2005-06.” This was in line with changes to the industry's operating environment and slower growth in the Pharmaceutical Benefits Scheme (PBS). The PBS is a government scheme for subsidising the cost of pharmaceuticals to the community. PBS reforms instituted over the five years through 2014-15 have presented the most fundamental changes to the scheme over its 60-year history. “Changes have included mandatory price cuts on many generic and off-patent drugs as part of the move towards mandatory price disclosure,” says Richardson. There has also been a change in the pricing mechanism (to weighted average disclosed prices) that determines wholesaler margins. The industry has also been influenced by changes to the Community Service Obligation (CSO). Negotiations for the terms of the next CSO for 2015 to 2020 are expected to commence later in 2014.

The industry exhibits a medium level of market share concentration. Major players include Sigma Pharmaceuticals Limited, Ebos Group Limited and Australian Pharmaceutical Industries Limited. In 2014-15, industry revenue is anticipated to fall by 3.8%, due to several factors. The industry is expected to contend with challenging conditions within the downstream retail pharmacy segment, patent expiries in view of the passing patent cliff and cuts to generic prices as the first round of simplified price disclosure cuts comes into effect on 1 October 2014. Revenue for 2014-15 is estimated at $11.4 billion, down from $13.3 billion in 2009-10. The Pharmaceuticals Wholesaling industry is expected to contract by an annualised 3.0% over the five-year period. These variables will continue to affect the industry in the next five years, particularly if other upstream pharmaceutical manufacturers follow Pfizer's 2011 example and implement exclusive distribution arrangements. In addition, the market environment will generate pressure for further change, as wholesalers move away from traditional distribution in favour of new business models with a stronger retail and professional services focus.

For more information, visit IBISWorld’s Pharmaceuticals Wholesaling report in Australia industry page.

Follow IBISWorld on Twitter: http://twitter.com/#!/ibisworldau.

IBISWorld industry Report Key Topics

The industry comprises companies that wholesale human-use pharmaceutical products, including prescription drugs, over-the-counter medicines and complementary or alternative medicines. It also covers companies involved in the wholesale of veterinary drugs and medicines. The products are obtained from the relevant upstream manufacturer and distributed to hospitals, veterinarians and various retail outlets, including pharmacies and supermarkets.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
International Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalisation
Major Companies
Operating Conditions
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognised as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every Australian industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Melbourne, IBISWorld serves a range of business, professional service and government organisations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com.au or call (03) 9655 3886.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12068774.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. New UT Arlington research could improve pharmaceuticals testing
2. Actos Bladder Cancer Allegations Attorney Help: Resource4thePeople Comments on Progress of Federal Litigation Involving Cancer Claims Filed against Takeda Pharmaceuticals
3. Global Pharmaceuticals & Medicine Manufacturing Industry Market Research Report from IBISWorld has Been Updated
4. Database tracks toxic side effects of pharmaceuticals
5. Fem Med Formulas Announces an Exclusive License Agreement with NewBridge Pharmaceuticals
6. Actos Bladder Cancer Allegation Lawyer: Resource4thePeople Reports New Cases Involving Cancer Claims Filed against Takeda Pharmaceuticals
7. OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
8. Biopharmaceuticals - A Global Market Overview
9. FDA Issues Letter to Sunovion Pharmaceuticals, Claims Patient Brochures Made by Company to Support Its Respiratory Drug Brovana Mislead, Parker Waichman LLP Notes
10. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013
11. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... June 24, 2017 , ... Doorknobs are for convenience, deadbolts ... as getting a guard dog or having an alarm system installed. But unless there ... forced entry. Yair Frenkel, owner of TX Premier Locksmith in Killeen, TX says: “In ...
(Date:6/23/2017)... , ... June 24, 2017 , ... Studies show evidence ... reduce the risk of visual loss in these patients. , But how often do ... or smoking cessation to patients at risk of or with early symptoms of AMD? ...
(Date:6/23/2017)... , ... June 23, 2017 , ... Goodcents Deli Fresh ... The restaurant is located at 4210 SW 21st St. Topeka, Kan. 66604 (near 21st ... of Graham Restaurant Group who owns three other locations in the Topeka and Bonner ...
(Date:6/23/2017)... ... , ... MD Now Urgent Care opened its newest location on ... marks the urgent care center's eighth location in Miami-Dade county. , The center's address ... The new clinic offers a wide array of services to patients in ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... financial planning, and related services to families and business owners in and around ... drive to benefit senior citizens in the area. , Meals on Wheels of ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... and INDIANAPOLIS , June 9, 2017 ... with diabetes. In a further effort to help spread ... by this condition, the International Diabetes Federation (IDF) and ... have come together for the second phase of the ... programme (BRIDGES 2), reaffirming their commitment to helping people ...
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq: ... care, today announced new findings demonstrating positive biochemical outcomes ... System One™. The data will be presented at ... Madrid, Spain . ... Improve Home Dialysis Network in Europe ...
Breaking Medicine Technology: